GREEN CROSS CORPORATION

Pharmaceutical preparations for treating the central nervous system; [ Radioactive pharmaceutical preparations for in vivo and in vitro diagnostic use; Pharmaceutical preparations for anus; ] Antibiotic preparations; [ Hypoglycemic agents; ] Pharmaceutical preparations for treating blood disorders; [ Blood plasma; Medicated serums for treatment of hair, skin and lips; Serotherapeutic medicines for the treatment and prevention of infectious diseases caused by bacteria or viruses; ] Pharmaceutical preparations for respiratory organs; Biological preparations for medical or veterinary purposes, namely, for the treatment and prevention of infectious diseases caused by bacteria or viruses; Cultures of microorganisms for medical purposes, except yeast; Pharmaceutical preparations for treatment of infectious diseases caused by bacteria or viruses; [ Pharmaceutical preparation for skin care; ] Human vaccine preparations; Vaccines against flu; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting metabolism; Veterinary preparations for the treatment and prevention of infectious diseases caused by bacteria or viruses; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for immunity adjustment; [ Pharmaceutical preparations for urogenital organs; Vitamin preparations; Preparations of trace elements for human and animal use, namely, nutritional supplements and vitamins for the treatment and prevention of infectious diseases caused by bacteria or viruses; Crude medicines for the treatment and prevention of infectious diseases caused by bacteria or viruses; Anti-inflammatory preparations; ] Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; [ Steroids; ] Allergy medications; Nutritional supplements, namely, nutritional supplements in tonic form and for use as alteratives for medical purposes; Pharmaceutical preparations for tumor treatment; Pharmaceutical preparations acting on the central nervous system

Blood plasma derivatives for medical purposes, namely, immune globulins including Rh immune globulin; Immunoglobulin reparations, namely, pharmaceutical immunoglobulin preparations for treatment of primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich Syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP); all the foregoing for patient treatment by injection or in liquid form by health professional